These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 11280550)

  • 1. Mean platelet volume: a useful marker of inflammatory bowel disease activity.
    Kapsoritakis AN; Koukourakis MI; Sfiridaki A; Potamianos SP; Kosmadaki MG; Koutroubakis IE; Kouroumalis EA
    Am J Gastroenterol; 2001 Mar; 96(3):776-81. PubMed ID: 11280550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated thrombopoietin serum levels in patients with inflammatory bowel disease.
    Kapsoritakis AN; Potamianos SP; Sfiridaki AI; Koukourakis MI; Koutroubakis IE; Roussomoustakaki MI; Manousos ON; Kouroumalis EA
    Am J Gastroenterol; 2000 Dec; 95(12):3478-81. PubMed ID: 11151880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombopoietin serum levels in patients with inflammatory bowel disease with and without previous thromboembolic events.
    Papa A; Danese S; Piccirillo N; Toriani-Terenzi C; Bartolozzi F; Piscaglia AC; Grillo A; Leone G; Gentiloni-Silveri N; Gasbarrini G; Gasbarrini A
    Hepatogastroenterology; 2003; 50(49):132-5. PubMed ID: 12630008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD40 and CD86 upregulation with divergent CMRF44 expression on blood dendritic cells in inflammatory bowel diseases.
    Vuckovic S; Florin TH; Khalil D; Zhang MF; Patel K; Hamilton I; Hart DN
    Am J Gastroenterol; 2001 Oct; 96(10):2946-56. PubMed ID: 11693331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mean platelet volume (MPV) in Crohn's disease patients].
    Douda T; Bures J; Rejchrt S; Kopácová M; Pecka M; Malý J
    Cas Lek Cesk; 2006; 145(11):870-3. PubMed ID: 17168422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory mediators and acute phase proteins in patients with Crohn's disease and ulcerative colitis.
    Niederau C; Backmerhoff F; Schumacher B; Niederau C
    Hepatogastroenterology; 1997; 44(13):90-107. PubMed ID: 9058126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of humoral markers of inflammation and dehydroepiandrosterone sulfate or cortisol serum levels in patients with chronic inflammatory bowel disease.
    Straub RH; Vogl D; Gross V; Lang B; Schölmerich J; Andus T
    Am J Gastroenterol; 1998 Nov; 93(11):2197-202. PubMed ID: 9820396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarkers of altered coagulation and fibrinolysis as measures of disease activity in active inflammatory bowel disease: a gender-stratified, cohort analysis.
    Shen J; Ran ZH; Zhang Y; Cai Q; Yin HM; Zhou XT; Xiao SD
    Thromb Res; 2009 Feb; 123(4):604-11. PubMed ID: 18499234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.
    Henriksen M; Jahnsen J; Lygren I; Stray N; Sauar J; Vatn MH; Moum B;
    Gut; 2008 Nov; 57(11):1518-23. PubMed ID: 18566104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary excretion of N-methylhistamine as a marker of disease activity in inflammatory bowel disease.
    Winterkamp S; Weidenhiller M; Otte P; Stolper J; Schwab D; Hahn EG; Raithel M
    Am J Gastroenterol; 2002 Dec; 97(12):3071-7. PubMed ID: 12492192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma levels of endothelin-1 in patients with Crohn's disease and ulcerative colitis.
    Letizia C; Boirivant M; De Toma G; Cerci S; Subioli S; Scuro L; Ferrari P; Pallone F
    Ital J Gastroenterol Hepatol; 1998 Jun; 30(3):266-9. PubMed ID: 9759593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of different measurements of intestinal permeability in inflammatory bowel disease.
    Howden CW; Robertson C; Duncan A; Morris AJ; Russell RI
    Am J Gastroenterol; 1991 Oct; 86(10):1445-9. PubMed ID: 1928036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma citrulline concentration: a reliable marker of small bowel absorptive capacity independent of intestinal inflammation.
    Papadia C; Sherwood RA; Kalantzis C; Wallis K; Volta U; Fiorini E; Forbes A
    Am J Gastroenterol; 2007 Jul; 102(7):1474-82. PubMed ID: 17459021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated serum eotaxin levels in patients with inflammatory bowel disease.
    Mir A; Minguez M; Tatay J; Pascual I; Peña A; Sanchiz V; Almela P; Mora F; Benages A
    Am J Gastroenterol; 2002 Jun; 97(6):1452-7. PubMed ID: 12094864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytokine tumor necrosis factor-alpha A promoter gene polymorphism at position -308 G-->A and pediatric inflammatory bowel disease: implications in ulcerative colitis and Crohn's disease.
    Sýkora J; Subrt I; Dìdek P; Siala K; Schwarz J; Machalová V; Varvarovská J; Pazdiora P; Pozler O; Stozický F
    J Pediatr Gastroenterol Nutr; 2006 May; 42(5):479-87. PubMed ID: 16707968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet factor 4 and beta-thromboglobulin in inflammatory bowel disease and giant cell arteritis.
    Vrij AA; Rijken J; Van Wersch JW; Stockbrügger RW
    Eur J Clin Invest; 2000 Mar; 30(3):188-94. PubMed ID: 10691994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease.
    Griga T; May B; Pfisterer O; Müller KM; Brasch F
    Hepatogastroenterology; 2002; 49(43):116-23. PubMed ID: 11941933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noninvasive markers in the assessment of intestinal inflammation in inflammatory bowel diseases: performance of fecal lactoferrin, calprotectin, and PMN-elastase, CRP, and clinical indices.
    Langhorst J; Elsenbruch S; Koelzer J; Rueffer A; Michalsen A; Dobos GJ
    Am J Gastroenterol; 2008 Jan; 103(1):162-9. PubMed ID: 17916108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistin is an inflammatory marker of inflammatory bowel disease in humans.
    Konrad A; Lehrke M; Schachinger V; Seibold F; Stark R; Ochsenkühn T; Parhofer KG; Göke B; Broedl UC
    Eur J Gastroenterol Hepatol; 2007 Dec; 19(12):1070-4. PubMed ID: 17998831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An overlooked indicator of disease activity in ulcerative colitis: mean platelet volume.
    Yüksel O; Helvaci K; Başar O; Köklü S; Caner S; Helvaci N; Abayli E; Altiparmak E
    Platelets; 2009 Jun; 20(4):277-81. PubMed ID: 19459134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.